Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmed S A Mady

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biopolymers|June 26, 2010
Recent developments in bisintercalator natural productsOlga E Zolova, Ahmed S A Mady, Sylvie Garneau-Tsodikova
Nucleic Acids Research|February 6, 2019
The WD40 domain of FBXW7 is a poly(ADP-ribose)-binding domain that mediates the early DNA damage responseQiang Zhang, Ahmed S A Mady, Yuanyuan Ma, et al.
Molecular Biosystems|April 13, 2011
Characterization of TioQ, a type II thioesterase from the thiocoraline biosynthetic clusterAhmed S A Mady, Olga E Zolova, María Álvarez San Millán, et al.
Chemmedchem|November 10, 2012
Directed modulation of protein kinase C isozyme selectivity with bisubstrate-based inhibitorsLoek T M van Wandelen, Jeroen van Ameijde, Ahmed S A Mady, et al.
Scientific Reports|July 7, 2018
Discovery of Mcl-1 inhibitors from integrated high throughput and virtual screeningAhmed S A Mady, Chenzhong Liao, Naval Bajwa, et al.
Molecular Cancer Therapeutics|September 11, 2013
A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivoFardokht Abulwerdi, Chenzhong Liao, Meilan Liu, et al.
ACS Pharmacology & Translational Science|September 19, 2025
Understanding the Functional Dependence and Inhibition of the Bcl‑2 Pro-Survival Proteins in a Wide Spectrum of Cancers toward Precision MedicineKarson J Kump, Ejaz Ahmad, Charles Foucar, et al.
Journal of Medicinal Chemistry|January 24, 2020
Discovery and Characterization of 2,5-Substituted Benzoic Acid Dual Inhibitors of the Anti-apoptotic Mcl-1 and Bfl-1 ProteinsKarson J Kump, Lei Miao, Ahmed S A Mady, et al.
Cancer Cell|August 10, 2021
PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunityJoseph M Gozgit, Melissa M Vasbinder, Ryan P Abo, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biopolymers|June 26, 2010
Recent developments in bisintercalator natural productsOlga E Zolova, Ahmed S A Mady, Sylvie Garneau-Tsodikova
Nucleic Acids Research|February 6, 2019
The WD40 domain of FBXW7 is a poly(ADP-ribose)-binding domain that mediates the early DNA damage responseQiang Zhang, Ahmed S A Mady, Yuanyuan Ma, et al.
Molecular Biosystems|April 13, 2011
Characterization of TioQ, a type II thioesterase from the thiocoraline biosynthetic clusterAhmed S A Mady, Olga E Zolova, María Álvarez San Millán, et al.
Chemmedchem|November 10, 2012
Directed modulation of protein kinase C isozyme selectivity with bisubstrate-based inhibitorsLoek T M van Wandelen, Jeroen van Ameijde, Ahmed S A Mady, et al.
Scientific Reports|July 7, 2018
Discovery of Mcl-1 inhibitors from integrated high throughput and virtual screeningAhmed S A Mady, Chenzhong Liao, Naval Bajwa, et al.
Molecular Cancer Therapeutics|September 11, 2013
A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivoFardokht Abulwerdi, Chenzhong Liao, Meilan Liu, et al.
ACS Pharmacology & Translational Science|September 19, 2025
Understanding the Functional Dependence and Inhibition of the Bcl‑2 Pro-Survival Proteins in a Wide Spectrum of Cancers toward Precision MedicineKarson J Kump, Ejaz Ahmad, Charles Foucar, et al.
Journal of Medicinal Chemistry|January 24, 2020
Discovery and Characterization of 2,5-Substituted Benzoic Acid Dual Inhibitors of the Anti-apoptotic Mcl-1 and Bfl-1 ProteinsKarson J Kump, Lei Miao, Ahmed S A Mady, et al.
Cancer Cell|August 10, 2021
PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunityJoseph M Gozgit, Melissa M Vasbinder, Ryan P Abo, et al.
Pageof 1